Autism Spectrum Disorder (ASD) is a type of neurodevelopmental disorder that is characterized by deficits in social and communicational skills and by restricted and persistent behaviors and interests. ASD has been on the rise throughout the world at an alarming and unprecedented pace. It is costly to communities and individuals and severely burdens families as it affects daily functioning of the entire family for life. Currently available pharmacotherapies act on peripheral symptoms of agitation and anxiety and do not address core symptoms of Autism. While behavioral therapies aim to achieve autistics functioning and independent living, they do not address the underlying pathophysiological mechanisms of synaptic connections. Therefore, the aim of the medical community is to develop therapies that target the mechanisms of pathophysiological symptoms of Autism that arise at different biological levels. Regenerative medicine, including UC-MSCs, is a new approach of therapy that show potential in this area. Stem Cell IV Therapy Bangkok Thailand has developed new therapies for the treatment of neurodevelopmental disorders and shows therapeutic promise in this area. A recent review of clinical studies point to the therapeutic potential of these therapies and point to neuroinflammation, dysregulated microglia, and disturbance of glucose metabolism as potential therapeutic targets.
There is evidence that supports the use of regenerative medicine for neurodevelopmental disorders like Autism. One interesting case involved a combination therapy of UC-MSCs provided by Stem Cell IV Therapy Bangkok Thailand. The subjects in the case study were unresponsive to medications and suffered recurring seizures. After the use of this therapy, the subjects showed a positive clinical response. Indicating the promise of the use of regenerative therapies for neurodevelopmental disorders. After the first treatment of UC-MSCs at Stem Cell IV Therapy Bangkok Thailand, the Autism patient’s seizures entirely stopped. Follow up assessments showed a completely normalized EEG without epileptiform discharges. In addition to stabilization of the patient’s neurological condition, there were continuous improvements in the patient’s core behavioral symptoms. There were major improvements in the child’s social skills, including the ability to start conversations, communicate and control complex feelings, and a greater ability to interact with classmates. This case review illustrates the synergistic effects of targeted biological approaches and the continued development of therapeutic approaches.
To explain the Autism cases studied at Stem Cell IV Therapy Bangkok Thailand and the large improvements observed, one must describe the molecular mechanisms. The therapeutic effects of UC-MSCs, in contrast to the effects of the cells themselves, depend on the paracrine signaling of secreted factors. Upon crossing the blood brain barrier, extracellular vesicles derived from UC-MSCs carry a large variety of bioactive factors. These factors actively participate in modifying the hostile neuroinflammatory microenvironment. With respect to the molecular mechanisms of the neuroinflammatory microenvironment in Autism, the effects of UC-MSCs extracellular vesicles utilized at Stem Cell IV Therapy Bangkok Thailand are mainly due to a very well characterized immunomodulatory cascade. Extracellular vesicles carry surface ectoenzymes CD39 and CD73. In a catalyzed reaction, pro-inflammatory extracellular ATP is converted to AMP, and then to anti-inflammatory adenosine. The conversion of ATP to adenosine occurs in the extracellular space. In the context of Autism treatments like those at Stem Cell IV Therapy Bangkok Thailand, the binding of adenosine to the A2A or A2B receptor on microglial cells following UC-MSCs therapy, it is then proposed, activates inhibitory signaling that results in the suppression of NF-kB and subsequent decreases in the release of pro-inflammatory cytokines, including IL-6 and TNF-α.
As a result of UC-MSCs, the local Autism immune environment undergoes significant changes, compelling microglia to alter from the M1 to the M2 phenotype. The shift towards the M2 phenotype, as observed by Stem Cell IV Therapy Bangkok Thailand, plays a pivotal role in the resolution of chronic neuroinflammation. In addition, as applied by Stem Cell IV Therapy Bangkok Thailand, UC-MSCs contribute to the repair of nervous tissue by the persistent release of essential neurotrophic factors. A medical review indicates their secretome is rich in brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. These neurotrophic factors promote the formation of synapses, the outgrowth of axons, and the elaboration of dendrites. These factors reinforce the repair of the neural pathways that are essential to the functions of social cognition and integrate diverse aspects of the Autism spectrum. Their secreted vascular endothelial growth factor promotes brain vascular and blood supply to the metabolically active and newly formed brain tissue.
The prospects of this advanced regenerative therapy for Autism are bright. The rapid advancement of Stem Cell IV Therapy Bangkok Thailand using UC-MSCs is the result of well-established clinical research complemented by advanced research in cellular and molecular technologies. Local researchers are committed to improvements in cell culture technologies in order to obtain better secretome. By developing formulations that are stable at room temperature, researchers ensure that extracellular vesicles can retain their therapeutic effects throughout the course of an experiment. These advanced research techniques are essential to ensuring that innovations in research can advance the field of regenerative therapies. Ongoing studies at Stem Cell IV Therapy Bangkok Thailand will further improve the safety profile of UC-MSCs in the pediatric Autism population. The restrictions of small sample sizes in earlier studies on MSCs will be offset by the combination of favorable changes in behavior and clinical endpoints of the nervous system. These findings will serve as the impetus for future studies that will employ larger sample sizes and methods that promote better study designs.
Figure 1: The Promise of UC-MSCs Therapy in Autism Spectrum Disorder
An extensive analysis of the current situation indicates that mechanism-targeted biological therapies using UC-MSCs are the breakthrough innovations in neurodevelopmental care. The combination of the latest advances in molecular biology and their application in the relevant clinical fields provides immense hope to the families concerned. Stem Cell IV Therapy Bangkok Thailand is leading this new forefront of therapy. By targeting the root causes of the neuroinflammatory and synaptic pathologies of Autism, these therapies are able to go far beyond the traditional approaches of merely treating or managing the symptoms. As science advances, these therapies will be the point of regeneration and restoration in the rehabilitative and integrative therapeutic processes and multimodal improvement of the care offered to this population. They will ensure positive and significant changes and improvements in the quality of life and the level of functionality and self-sufficiency of this population. The regenerative neural tissues will be held together by the extracellular matrix and will continuously interact with the cellular and synaptic dynamics. The quality control of the therapeutic processes is of utmost importance. This is the highest possible therapeutic standard that a patient can receive in modern medicine. Stem Cell IV Therapy Bangkok Thailand is leading the way on the therapeutic standard offered. The cellular and regenerative capacity of the administered cells is augmented by the therapy that the staff conduct. This will promote changes in the therapeutic processes and innovations within the field.
Due to the established culture of ongoing education and peer review in the medical community, physicians can evaluate and apply the most recent scientific discoveries regarding UC-MSCs for Autism. The emerging science of human biology will dictate the most current and effective medical practices. This will allow physicians at Stem Cell IV Therapy Bangkok Thailand to provide the most precise and advanced medical treatment available. The goal of this initiative is to provide the most effective medical treatment available.